India
oi-Ajay Joseph Raj P
New Delhi, Jan 05: On January 2, the Drugs Controller General of India (DCGI), announced the approval for COVID vaccines of Oxford-AstraZeneca-manufactured by the Serum Institute in India-and, of Bharat Biotech, saying that both vaccines would be administered in two doses each. The approval by the DCGI was given on the basis of recommendations submitted by a coronavirus subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
Dismissing safety concerns, Somani asserted that no vaccine with even the slightest safety concern would be approved by DCGI. “The vaccines are 110 per cent safe. Some side effects like mild fever, pain and allergy are common for every vaccine,” said the DCGI.
Though the officials came up with much assurances, several Opposition leaders have questioned the approval of the vaccines, particularly that of Bharat Biotech….
